Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
One tablet may be administered once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly.
Assessment of renal function is recommended before and periodically during treatment with this drug.
If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or greater, no dosage adjustment based on renal function is required.
Do not administer this drug if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.
Improvement of glycemic control in patients with type 2 diabetes mellitus
View approved original textHide original text
This medication is used as an adjunct to dietary and exercise therapy to help improve blood sugar control in patients with type 2 diabetes who are suitable for combined treatment with sitagliptin and pioglitazone. In other words, it helps effectively manage blood sugar levels to aid in diabetes treatment.
Dosage and Administration
Adult dosage
One tablet may be administered once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly.
Assessment of renal function is recommended before and periodically during treatment with this drug.
If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or greater, no dosage adjustment based on renal function is required.
Do not administer this drug if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.
Precautions
This medication contains two ingredients, sitagliptin and pioglitazone.
First, the sitagliptin component may rarely cause serious allergic reactions, so if symptoms such as skin rash, hives, or difficulty breathing occur after taking the medication, you should stop taking it immediately and consult a doctor.
Also, sitagliptin may carry a risk of causing pancreatitis, so if you experience abdominal pain, vomiting, or loss of appetite while taking it, you should inform a healthcare provider immediately.
The pioglitazone component can exacerbate or cause heart failure, so patients with heart failure or those with a history of heart failure should not take this medication, and symptoms of heart failure such as weight gain, shortness of breath, and leg swelling should be vigilantly monitored during treatment.
This medication should not be administered to patients with active bladder cancer or a previous history of bladder cancer, and if symptoms such as hematuria or urgency occur during urination, you should notify a doctor immediately.
Patients with severely impaired kidney function should not take this medication, and those with slightly impaired kidney function should have dosage adjustments as needed, with regular kidney function tests recommended.
Pregnant women or those who may become pregnant should not take this medication, and premenopausal women should take appropriate contraceptive measures to prevent pregnancy.
While taking this medication, you should pay attention to symptoms of hypoglycemia, as the risk of hypoglycemia may increase when combined with other diabetes medications.
Additionally, this medication may cause edema and weight gain, so if these symptoms occur, you should consult a healthcare provider.
Rarely, symptoms of abnormal liver function and liver failure have been reported, so if you experience symptoms indicative of liver damage such as fatigue, jaundice, or abdominal pain, you should seek medical attention immediately.
Finally, this medication may increase the risk of fractures, so especially female patients should pay attention to bone health and receive appropriate tests as needed.
Side effects
Hypersensitivity
anaphylaxis
angioedema
Stevens-Johnson syndrome
acute pancreatitis
congestive heart failure
fluid retention
edema
hypoglycemia
upper respiratory tract infection
Show 64 moreCollapse
nasopharyngitis
headache
diarrhea
abdominal pain
nausea
constipation
severe joint pain with disability
bullous pemphigoid
myalgia
limb pain
back pain
interstitial lung disease
pruritus
thrombocytopenia
rhabdomyolysis
dyspepsia
dizziness
increased blood triglycerides
elevated low-density lipoprotein
hyperglycemia
pneumonia
diabetic complications
metabolic acidosis
falls
cardiac arrest
elevated liver enzymes
liver failure
acute renal failure
vomiting
severe joint pain
bullous pemphigoid
thrombocytopenia
macular edema
hepatotoxicity
worsening of liver disease
urticaria
eczema
joint pain
knee abnormalities
arm weakness
proteinuria
increased blood creatinine
anxiety
insomnia
drowsiness
herpes simplex
blurred vision
hypertension
heart failure
orthostatic hypotension
palpitations
stroke
sexual dysfunction
myocardial infarction
abdominal pain
heart failure
weight gain
urinary tract infection
low back pain
dizziness
abdominal distension
increased blood creatine kinase
hypertension
fractures
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius.
By storing it this way, the efficacy of the medication can be maintained for a longer time.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.